Lataa...
New insights into the mechanism of action of immune checkpoint antibodies
Preclinical models have been developed and applied to predict the clinical efficacy of immune checkpoint antibodies. Now these models can be used to dissect the mechanisms by which such immunotherapeutic antibodies work and to build the rationale for combining immune checkpoint-targeting antibodies...
Tallennettuna:
| Julkaisussa: | Oncoimmunology |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292403/ https://ncbi.nlm.nih.gov/pubmed/25610751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.954869 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|